- Brandsma D,
Stalpers L,
Taal W,
et al.
Clinical features,
mechanisms and management of pseudoprogression in malignant gliomas.
Lancet Oncol 2008; 9: 453–61.
- Essig M,
Anzalone N,
Combs SE,
et al.
MR Imaging of Neoplastic Central Nervous System Lesions: Review and Recommendations for Current Practice.
AJNR Am J Neuroradiol 2012; 33: 803–17.
- Barajas R,
Chang J,
Segal M,
et al.
Differentiation of Recurrent Glioblastoma Multiforme from Radiation Necrosis after External Beam Radiation Therapy with Dynamic Susceptibility weighted Contrast-enhanced Perfusion MR Imaging.
Radiology 2009; 253: 486-96.
- Park SM,
Kim HS,
Jahng G-H,
et al.
Combination of high-resolution susceptibility-weighted imaging and the apparent diffusion coefficient: added value to brain tumour imaging and clinical feasibility of non-contrast MRI at 3 T.
The British Journal of Radiology 2010; 83: 466–75.
- Detre JA,
Wang J,
Wang Z,
et al.
Arterial spin-labeled perfusion MRI in basic and clinical neuroscience.
Current Opinion in Neurology 2009; 22: 348–55.
- Pollock JM,
Tan H,
Kraft RA,
et al.
Arterial Spin Labeled MRI Perfusion Imaging: Clinical Applications.
Magn Reson Imaging Clin N Am 2009; 17(2): 315–38.
- Warmuth C,
Gunther M,
Zimmer C.
Quantification of Blood Flow in Brain Tumors: Comparison of Arterial Spin Labeling and Dynamic Susceptibility weighted Contrast-enhanced MR Imaging.
Radiology 2003; 228(2): 523-32.
- Weber MA,
Kroll A,
Günther M,
et al.
Noninvasive measurement of relative cerebral blood flow with the blood bolus MRI arterial spin labeling: basic physics and clinical applications.
Radiologe 2004; 44(2): 164-73.
- Server A,
Døli Orheim TE,
Graff BA,
et al.
Diagnostic examination performance by using microvascular leakage,
cerebral blood volume,
and blood flow derived from 3-T dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging in the differentiation of glioblastoma multiforme and brain metastasis.
Neuroradiology 2011; 53: 319–30.
- Yamashita K,
Yoshiura T,
Hiwatashi A,
et al.
Differentiating primary CNS lymphoma from glioblastoma multiforme: assessment using arterial spin labeling,
diffusion-weighted imaging,
and 18F-fluorodeoxyglucose positron emission tomography.
Neuroradiology 2012; DOI 10.1007/s00234-012-1089-6.